Med Fusion & VERIGENE® Testimonial

Med Fusion & VERIGENE® Testimonial
Neelam Dhiman, PhD, Scientific Director, Molecular ID at med fusion in Lewisville, TX speaks about the need for rapid testing for Sepsis. By implementing the VERIGENE® Bloodstream Infection assays in their laboratory, they have been able to reduce time to patient therapy by 18 hours. med fusion has also seen cost savings coming from delivering rapid results, better patient care, reduced stay in the hospital and appropriate antibiotic therapy which helps reduce antimicrobial breeding in the population.
Sepsis is a huge problem with a very high mortality rate where every hour counts. Rapid diagnostics provide the identification and susceptibility of the patient to the physician as quickly as possible. VERIGENE® blood culture tests have allowed med fusion to tell the physician results within 3 hours. Rapid results, better patient care, and reduced hospital stays have all helped to provide cost savings. Applying appropriate antibiotic therapy at the right time for the right patient helps minimize antimicrobial resistance.
The VERIGENE System offers automated, cost-effective multiplex capabilities that rapidly and accurately detect infectious pathogens and drug resistance markers, without relying on time-consuming culture methods.
Delivery of this time-critical information enables clinicians to provide targeted patient care more quickly, potentially leading to improved patient outcomes, lower costs, optimized antibiotic therapy, reduced spread of antibiotic resistance, and most importantly, saved lives.
VERIGENE is powering faster treatment decisions in more than half of the top U.S. hospitals. VERIGENE’s ease of use makes it a valuable system for use in both hospital-based and reference laboratories.
Tests run on the VERIGENE platform are designed to target infections in the bloodstream, respiratory tract, and gastrointestinal tract.
www.luminexcor...